Ancient Chinese Medicine: Controlling shareholders acting in concert have cumulatively increased their shareholding by 2.07%.

The announcement of Guhan Traditional Chinese Medicine stated that, as of the date of the announcement, Shanghai Salexian, one of the concerted actors of the controlling shareholder Hunan Salexian, has accumulated an increase of 4.9502 million shares through centralized bidding trading, accounting for 2.07% of the total share capital. After this equity change, Hunan Salexian and its concerted actors hold a total of 64.6572 million shares, accounting for 27.00% of the total share capital, with the change affecting the integer multiple of 1%. Shanghai Salexian originally planned to increase its holdings by no less than 20 million yuan within six months, but the implementation of the current plan has not been completed yet, and there are uncertainties and risks involved.